Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy
Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy
Sponsor: St. Luke's-Roosevelt Hospital Center
Terminated
low enrollment
Other terminated trials from St. Luke's-Roosevelt Hospital Center
- Prostate Cancer · Phase PHASE1/PHASE2 · Nov 2016
- Depression · Phase NA · Apr 2016
- Headache · Phase NA · Oct 2005
See all terminations from St. Luke's-Roosevelt Hospital Center
A PHASE4 clinical study on Hemorrhoid, this trial is terminated or withdrawn. The trial is conducted by St. Luke's-Roosevelt Hospital Center and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Jan 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2019 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Luke's-Roosevelt Hospital Center
For direct contact, visit the study record on ClinicalTrials.gov .